MUCOPOLYSACCHARIDOSIS TYPE II
Abstract
Article is devoted to one of the orphan diseases — mucopolysaccharidosis (MPS), which is the result of any lysosomal enzyme deficiency (which determines the type of illness). The most common is the MPS type II (Hunter syndrome), developing as a result of deficiency of the enzyme alpha-L-iduronosulphatsulphataze. The authors are observing the largest group of children with this pathology in the Russian population — 40 patients. On the example of their own clinical cases the only existing on the date the pathogenetic treatment is provided — replacement therapy with idursulphase that significantly improves the disease prognosis.
Key words: MPS, types, Hunter syndrome, clinical course, diagnosis, treatment, prognosis, children.
About the Authors
N.D. Vashakmadze
Scientific Center of Children’s Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
L.S. Namazova-Baranova
Scientific Center of Children’s Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
A.K. Gevorkyan
Scientific Center of Children’s Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
L.M. Kuzenkova
Scientific Center of Children’s Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
A.D. Khristochevskiy
Scientific Center of Children’s Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
L.M. Vysotskaya
Scientific Center of Children’s Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
A.S. Dadashev
Scientific Center of Children’s Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
For citations:
Vashakmadze N.,
Namazova-Baranova L.,
Gevorkyan A.,
Kuzenkova L.,
Khristochevskiy A.,
Vysotskaya L.,
Dadashev A.
MUCOPOLYSACCHARIDOSIS TYPE II. Pediatric pharmacology. 2011;8(3):66-68.
Views:
595